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&p.1:Abstract. The hemolytic-uremic syndrome (HUS) typi-
cally presents in toddlers or older children after an epi-
sode of bloody diarrhea caused by Escherichia coli
0157:H7. However, numerous ‘‘atypical’’ presentations
have been described, including familial cases. Here we
describe what we believe to be the first report of famil-
ial HUS in a premature infant during the neonatal peri-
od.
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Introduction
The hemolytic-uremic syndrome (HUS) typically
presents in toddlers or older children after an episode of
bloody diarrhea caused by Escherichia coli0157:H7 [1].
However, numerous ‘‘atypical’’ presentations have been
described, including familial and non-diarrhea-associat-
ed cases [2]. In this report, we describe the presentation
of HUS in a premature infant who had an older sibling
who was also affected by HUS in infancy. We believe
this to be the first report of familial HUS in a premature
infant during the neonatal period.
Case reports
Case 1
Patient 1 was a white female, twin B of a dizygotic pair, born at
32 weeks’ estimated gestational age by cesarean section to a 31-
year-old gravida 3 para 2 mother, at an outlying hospital. Pregnan-
cy was complicated only by premature onset of labor, which failed
to respond to terbutaline and magnesium sulfate tocolysis. The
mother was also given betamethasone to promote fetal lung matu-
rity and ampicillin in the immediate prenatal period. The infant
weighed 1,675 g at birth, and was noted to have poor color and
respiratory effort immediately after delivery, and was therefore
intubated and mechanically ventilated. No umbilical catheters
were placed. Initial physical examination was remarkable only for
evidence of respiratory distress and decreased tone.
Her early course was remarkable for mild respiratory distress
syndrome, a negative initial sepsis work-up (ampicillin and cefo-
taxime were given for 48 h), apnea of prematurity that was treated
with aminophylline, and mild non-hemolytic jaundice. Also, due
to hypotonia, dysconjugate eye movements, and a static head cir-
cumference noted over the first 2 weeks of life, a neurology con-
sultation was requested. The neurologist obtained chromosome
analysis, a urine metabolic screen, and an electroencephalogram
(EEG). The EEG was read as normal, the metabolic screen was
negative, and the chromosome analysis was normal. Cranial ultra-
sonography had previously revealed a structurally normal brain
without intraventricular hemorrhage.
On day of life (DOL) 15 the infant became severely hyperten-
sive, for which an evaluation was performed. Urinalysis revealed
hematuria and proteinuria. Blood urea nitrogen (BUN) and creati-
nine were elevated (Table 1); they had not been previously deter-
mined. Renal ultrasonography revealed normal-appearing paren-
chyma and normal vasculature. The next day she was noted to be
thrombocytopenic. A peripheral blood smear showed burr cells,
acanthocytes, and schistocytes. Cultures were obtained and antibi-
otics begun. Over the next 4 days she remained thrombocytopenic
(Table 1) and became anemic, for which packed red cell transfu-
sions were given. Neurologically the baby was lethargic and wors-
ening apnea necessitated re-institution of mechanical ventilation.
On DOL 17 she experienced a seizure, which was treted with phe-
nobarbital. Repeat cranial ultrasonography was unchanged.
Through DOL 19 she maintained a brisk urine output, while her
BUN and creatinine continued to rise (Table 1).
From DOL 19 she experienced progressive oliguria, unrespon-
sive to furosemide administration. Worsening hypertension was
treated, unsuccessfully, with hydralazine. Concomitant with her
decreased urine output was a weight gain of nearly 130 g. Blood
cultures were negative.
On DOL 20 the infant was transferred to the University of
Michigan Medical Center (UMMC) for management of her refrac-
tory hypertension and renal failure. Upon arrival at UMMC, her
physical examination was normal except for a blood pressure of
140/93 mmHg. The infant was profoundly anemic and thromb-
ocytopenic. Fibrinogen level was depressed and prothrombin time
as well as fibrinogen split products were modestly elevated. Bio-
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chemical analysis of serum revealed: sodium 130 mEq/l, potassi-
um 3.0 mEq/l, calcium 8.2 mg/dl, and phosphorus 11.1 mg/dl.
Serum protein was 4.0 g/dl, albumin 2.2 g/dl. BUN, creatinine,
and lactate dehydrogenase (LDH) were elevated (Table 1). The di-
agnosis of HUS was made shortly after the infant’s arrival. A fa-
milial variant was suspected based on a positive family history; a
sibling with HUS had been cared for at UMMC 14 months prior
to patient 1’s admission (this history had not been obtained at the
referring hospital).
Initial management consisted of a double volume exchange
transfusion of red blood cells and plasma, as well as a platelet
transfusion. Infusions of fresh-frozen plasma (10 ml/kg), given
twice daily, were started and continued for several days after the
exchange. The hypertension was treated with labetalol and hydral-
azine infusions. The next morning, discussions were held with the
family and a dialysis catheter and central vascular catheter were
placed and peritoneal dialysis begun. Due to the poor prognosis of
the disease, the option of discontinuing support was offered to the
family, but they wished to continue maximal medical manage-
ment.
On dialysis the patient’s hypertension resolved, which allowed
rapid weaning of all antihypertensives. Urea nitrogen, creatinine,
and LDH consistently decreased (Table 1). She required only one
further packed red blood cell transfusion, and no further platelet
transfusions. Hypoalbuminemia and edema were treated with a
25% albumin infusion. The only sign of central nervous system
abnormality was her persistent dysconjugate gaze. Seizures did
not recur and phenobarbital was discontinued. Dialysis was dis-
continued on DOL 30, due to leakage of dialysate around the Ten-
ckhoff exit site. During the next few days off dialysis, the infant
experienced increasing urine output and decreasing urea nitrogen
and creatinine. She was extubated on DOL 34. On DOL 36 hyper-
tension recurred and was treated with oral antihypertensives. On
DOL 43 her Tenckhoff was removed. She was discharged soon
thereafter with stable renal function (Table 1) and was thriving.
C3 values, measured during the acute phase of her illness (53
mg/dl), remained low (61 mg/dl) months after her first episode of
HUS. However, her total CH50 values were normal during her hos-
pitalization and during convalescence.
At approximately 7 months of age, the patient presented to her
local physician with extreme irritability and dark urine, and was
readmitted to UMMC. Laboratory studies were significant for he-
maturia, proteinuria, and thrombocytopenia (Table 1). The diagno-
sis of recurrent, familial HUS was made, and extensive discus-
sions were held with the family regarding therapeutic options, in-
cluding plasmapheresis. Given her poor long-term prognosis, it
was decided to provide comfort care only, and she died 3 days af-
ter admission. No autopsy was performed.
The patient’s twin sibling, who did not experience any signs or
symptoms suggestive of HUS in the neonatal period, was last seen
in follow-up at UMMC at 6 months of age. At that time she was
developing normally and had no evidence of renal disease. C3 and
CH50 determinations have not been performed in her case.
Case 2
Patient 2, the older sister of patient 1, presented at 4 months of
age with feeding intolerance and irritability approximately 2
weeks after surgical placement of a feeding gastrostomy. There
was no history of vomiting or diarrhea, but she did have a low-
grade fever and symptoms of an upper respiratory infection. Past
medical history was significant for microencephaly, a Dandy-
Walker malformation, and failure to thrive. Physical examination
was remarkable for tachycardia, hypertension, pallor, and mild pe-
ripheral edema. Initial laboratory studies revealed mild anemia,
hyponatremia, and a normal platelet count. Creatinine was 0.6
mg/dl, up from 0.2 mg/dl 2 weeks previously.
She rapidly developed progressive thrombocytopenia and azo-
temia, as well as a markedly elevated LDH of 1,863 IU/l. Hypten-
sion persisted, and she developed progressive oliguria. Because of
extreme irritability, a head computed tomographic (CT) scan was
obtained, and revealed a left posterior fossa hemorrhage. A Tenck-
hoff catheter was placed 4 days after admission and dialysis was
initiated. Renal function returned after approximately 9 days of
peritoneal dialysis. She required multiple transfusions of packed
red cells during her course. Hypertension remained difficult to
control throughout her hospitalization, ultimately requiring a com-
bination of three antihypertensives. Neurological status remained
stable, with no further hemorrhages seen on follow-up CT scan-
ning. Discharge was delayed because of feeding difficulties, but
she was eventually discharged on hospital day 25 with a stable
creatinine of 0.2 mg/dl, hemoglobin of 10.6 g/dl, and platelet
count of 513,000/mm3.
Discussion
HUS, first described by Gasser in 1955, has since been
shown to occasionally occur in multiple members of the
same family. Fison [3], in 1956, reported what is thought
to be the first occurrence of HUS in siblings. Kaplan et
al. [2], in 1975, examined HUS in 83 siblings from 41
families. They described two groups: the siblings from
group one families had onset of their disease within a
short time of each other and a good prognosis; while
group two patients had more than 1 year between occur-
rences of the disease in family members and a much
worse prognosis. They postulated that there was a genet-
ic predisposition to the disease in the patients in group
Day BUN Creatinine Hematocrit Platelet count LDH
of life
12 – – 44.5 306,000/mm3 –
15 58 mg/dl 1,3 mg/dl – – –
16 – – – 59,000/mm3 –
18 115 mg/dl 3.2 mg/dl – – –
20 116 mg/dl 2.8 mg/dl 24.3 10,000/mm3 2,966 IU/l
22 72 mg/dl 1.8 mg/dl 32.4 26,000/mm3 937 IU/l
26 20 mg/dl 1.0 mg/dl 36.3 137,000/mm3 282 IU/l
30 15 mg/dl 1.0 mg/dl 30 182,000/mm3 251 IU/l
43 9 mg/dl 0.4 mg/dl 34.7 489,000/mm3 –
Second 45 mg/dl 0.3 mg/dl 35.5 18,000/mm3 2,289 IU/l
admission
BUN, Blood urea nitrogen; LDH, lactate dehydrogenase&/tbl.b:
Table 1.Selected laboratory values in patient 1&/tbl.c:&tbl.b:
784
The prognosis in familial, non-diarrhea-associated
HUS is dismal. The mortality rate is greater than 90% in
the autosomal dominant form and 70% in patients with
the autosomal recessive form [3]. Many patients have re-
lapses, or a progressive course in some cases requiring
renal transplantation [4]. Genetic counselling should be
offered to the family of the child with the diagnosis of
familial HUS. DNA testing is not yet available for this
disorder, but a registry has been established and blood
samples are being collected for future analysis (B. Ka-
plan, personal communication).
In summary, we present what we believe to be the
first case report of a premature infant with familial HUS
presenting in the neonatal period. Diagnosis of this dis-
ease in a premature baby expands the age spectrum of
this disease and adds to the differential diagnosis of the
triad of renal failure, thrombocytopenia, and hemolytic
anemia in the premature neonate.
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two. This classification has been further refined to typi-
cal or diarrhea-associated HUS (Kaplan’s group one,
D+) and atypical HUS (group two, D−). Two subtypes of
atypical HUS are now recognized: sporadic and familial
[3]. Autosomal dominant and recessive forms of the fa-
milial disease have been described [4]. Although the
pathogenesis of inherited HUS remains unknown, com-
plement abnormalities [5] and defects in the metabolism
and function of prostacyclin have been implicated [6].
Autosomal recessive cobalamin C defect has also been
associated with HUS; the pathophysiologic mechanism
is thought to be endothelial damage as a result of accu-
mulation of homocysteine in the plasma of these patients
[7]. Kaplan and Kaplan [4] have recommended, due to
the abnormal complement profiles demonstrated in many
families with inherited HUS, that a serum C3 and CH50
be obtained in patients suspected of this diagnosis.
Diagnosis of a familial variant of HUS rests on the
history of another family member affected with HUS at
a remote time, or recurrence of the disease in the patient
or a family member, both of which characterized patient
1. Other clues that HUS may be familial include an atyp-
ical or no prodromal illness, predominantly arteriolar
changes on renal biopsy specimens, a slowly progressive
course, or recurrence after renal transplantation [4]. The
absence of the disease in the parents and an older brother
of patient 1, as well as her twin, leads us to believe that
this is a case of autosomal recessive transmission of the
disease. The parents in this case are not related.
HUS has been previously described in term neonates,
with onset as young as 2 days of age [8]. The differential
diagnosis of thrombocytopenia, hemolytic anemia, and
renal failure in this age group should include sepsis with
acute renal failure and disseminated intravascular coagu-
lation, bilateral renal vein thrombosis, and thrombotic
thrombocytopenia purpura (TTP). Sepsis was excluded
in this case on the basis of negative cultures and no ante-
cedent hypotension before onset of the acute renal fail-
ure. Bilateral renal vein thromboses were unlikely, based
on a negative renal ultrasound examination. TTP has
been seen in infants [4]. However, it typically affects
adults, and consists variably of hemolytic anemia,
thrombocytopenia, mild renal disease, fever, and promi-
nent neurological symptoms. The renal failure and the
lack of both fever and severe neurological symptomolo-
gy in this patient mitigate against the diagnosis of TTP.
Treatment of familial HUS focuses on the acute phase
of the illness, and is primarily supportive. The hyperten-
sion is often severe and is thought to be mediated by the
renin-angiotensin system. Angiotensin converting en-
zyme inhibition may be necessary [9]. Plasma infusions
[10] and plasmapheresis [11] have been advocated, but
without much evidence to support their potential benefit.
An exchange transfusion was performed during patient
1’s first episode because plasmapheresis was not techni-
cally feasible.
